118 related articles for article (PubMed ID: 2146517)
1. Clinical significance of standard CD assessment in acute leukemia.
Tupitsyn NN; Babusíková O; Baryshnikov AYu ; Ujházy P; Kadagidze ZG; Mahonova LA; Peterson IS; Protasova AK; Drozdova TS; Artemjev AK
Neoplasma; 1990; 37(4):431-8. PubMed ID: 2146517
[TBL] [Abstract][Full Text] [Related]
2. Expression of a novel surface antigen MKW in childhood acute leukemia has prognostic significance.
Koehler M; Schell MJ; Behm FG; Raimondi SC; Woodruff LS; Mirro J
Leukemia; 1991 Jan; 5(1):41-8. PubMed ID: 1999957
[TBL] [Abstract][Full Text] [Related]
3. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
4. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
5. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
6. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and analysis of the clinical course of T-phenotype acute lymphoblastic leukemia.
Babusíková O; Hrivnáková A; Cáp J; Ujházy P
Neoplasma; 1988; 35(6):683-90. PubMed ID: 2975765
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
9. [Immunologic prognosis in hemoblastoses in children].
Tupitsyn NN; Kadagidze ZG; Baryshnikov AIu; Makhonova LA; Maiakova SA; Kiselev AV; Peterson IS; Morozova OV; Gordina GA; Sholokhova EN
Vopr Onkol; 1990; 36(6):689-93. PubMed ID: 2198697
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
11. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
12. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
14. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J
Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
[TBL] [Abstract][Full Text] [Related]
15. Myeloid antigen expression in adult acute lymphoblastic leukemia: clinicohematological correlations and prognostic relevance.
Ferrara F; De Rosa C; Fasanaro A; Mele G; Finizio O; Schiavone EM; Spada OA; Rametta V; Del Vecchio L
Hematol Pathol; 1990; 4(2):93-8. PubMed ID: 2373674
[TBL] [Abstract][Full Text] [Related]
16. Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia.
Gramatzki M; Ludwig WD; Burger R; Moos P; Rohwer P; Grünert C; Sendler A; Kalden JR; Andreesen R; Henschke F; Moldenhauer G
Exp Hematol; 1998 Dec; 26(13):1209-14. PubMed ID: 9845376
[TBL] [Abstract][Full Text] [Related]
17. [Immunophenotypic study of acute myeloid leukemia (AML): biological significance and prognostic implications].
Rigolin GM; Latorraca A; Moretti S; Previati R; Lanza F
Boll Soc Ital Biol Sper; 1993 May; 69(5):301-5. PubMed ID: 8129911
[TBL] [Abstract][Full Text] [Related]
18. The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance.
Lauria F; Raspadori D; Ventura MA; Rondelli D; Testoni N; Tosi P; Michieli M; Damiani D; Motta MR; Tura S
Stem Cells; 1995 Jul; 13(4):428-34. PubMed ID: 7549902
[TBL] [Abstract][Full Text] [Related]
19. [The diagnostic significance of blast immunophenotype assay in patients with acute leukemia].
Piatoska-Jakubas B; Pituch-Noworolska A; Skotnicki AB; Balana-Nowak A
Acta Haematol Pol; 1996; 27(1):33-41. PubMed ID: 8629441
[TBL] [Abstract][Full Text] [Related]
20. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]